[go: up one dir, main page]

SI3046548T1 - Tableta, ki vsebuje krospovidon - Google Patents

Tableta, ki vsebuje krospovidon

Info

Publication number
SI3046548T1
SI3046548T1 SI201431515T SI201431515T SI3046548T1 SI 3046548 T1 SI3046548 T1 SI 3046548T1 SI 201431515 T SI201431515 T SI 201431515T SI 201431515 T SI201431515 T SI 201431515T SI 3046548 T1 SI3046548 T1 SI 3046548T1
Authority
SI
Slovenia
Prior art keywords
crospovidone
tablet
Prior art date
Application number
SI201431515T
Other languages
English (en)
Inventor
Abraham Cornelis Lardee
Original Assignee
Centrient Pharmaceuticals Netherlands B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centrient Pharmaceuticals Netherlands B.V. filed Critical Centrient Pharmaceuticals Netherlands B.V.
Publication of SI3046548T1 publication Critical patent/SI3046548T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI201431515T 2013-09-20 2014-09-18 Tableta, ki vsebuje krospovidon SI3046548T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13185368 2013-09-20
PCT/EP2014/069852 WO2015040093A1 (en) 2013-09-20 2014-09-18 Tablet comprising crospovidone
EP14766730.7A EP3046548B1 (en) 2013-09-20 2014-09-18 Tablet comprising crospovidone

Publications (1)

Publication Number Publication Date
SI3046548T1 true SI3046548T1 (sl) 2020-04-30

Family

ID=49223642

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201431515T SI3046548T1 (sl) 2013-09-20 2014-09-18 Tableta, ki vsebuje krospovidon

Country Status (11)

Country Link
US (1) US10159647B2 (sl)
EP (1) EP3046548B1 (sl)
CN (1) CN105555261B (sl)
DK (1) DK3046548T3 (sl)
ES (1) ES2780874T3 (sl)
HU (1) HUE048496T2 (sl)
PL (1) PL3046548T3 (sl)
PT (1) PT3046548T (sl)
RS (1) RS60054B1 (sl)
SI (1) SI3046548T1 (sl)
WO (1) WO2015040093A1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
JP2022519906A (ja) 2019-02-19 2022-03-25 ギリアード サイエンシーズ, インコーポレイテッド Fxrアゴニストの固体形態
US20200315972A1 (en) * 2019-03-11 2020-10-08 Gilead Sciences, Inc. Formulations of a compound and uses thereof
CN116157023A (zh) * 2020-07-24 2023-05-23 帝斯曼知识产权资产管理有限公司 新型速溶片剂
CN113274357B (zh) * 2021-05-28 2022-12-27 广州白云山医药集团股份有限公司白云山制药总厂 一种阿莫西林药物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9200139A (en) 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
ID23673A (id) 1997-02-14 2000-05-11 Smithkline Beecham Lab Pharma Formulasi farmasi yang terdiri dari amoksicilin dan klavulanat
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US20020006433A1 (en) * 1999-04-29 2002-01-17 Nigel P. Davidson Pharmaceutical formulations

Also Published As

Publication number Publication date
US10159647B2 (en) 2018-12-25
RS60054B1 (sr) 2020-04-30
HUE048496T2 (hu) 2020-07-28
EP3046548A1 (en) 2016-07-27
ES2780874T3 (es) 2020-08-27
CN105555261A (zh) 2016-05-04
EP3046548B1 (en) 2020-02-12
PL3046548T3 (pl) 2020-07-13
DK3046548T3 (da) 2020-04-27
WO2015040093A1 (en) 2015-03-26
CN105555261B (zh) 2020-02-11
US20160193153A1 (en) 2016-07-07
PT3046548T (pt) 2020-03-04

Similar Documents

Publication Publication Date Title
GB201306312D0 (en) Tablet case
GB201322602D0 (en) Pharmaceutical compounds
IL240846A0 (en) drug combination
GB201302901D0 (en) Ubuntu tablet
GB201306610D0 (en) Pharmaceutical compounds
HUE044430T2 (hu) Gyógyszerkombinációk
ZA201602047B (en) Pharmaceutical compounds
IL241350A0 (en) Subprevir tablets
PT3046548T (pt) Comprimido compreendendo crospovidona
PT2946780T (pt) Comprimido que contém 5-hidroxi-1h-imidazol-4-carboxamida
GB201312386D0 (en) Pharmaceutical compounds
EP3069714A4 (en) Tablet
GB201317166D0 (en) Pharmaceutical compounds
GB201316662D0 (en) Pharmaceutical Combination
GB201316780D0 (en) Pharmaceutical compounds
GB201316791D0 (en) Pharmaceutical Compounds
GB201315734D0 (en) Pharmaceutical compounds
GB201315733D0 (en) Pharmaceutical compounds
GB201312464D0 (en) Pharmaceutical compounds
GB201308780D0 (en) Pharmaceutical compounds
GB201308782D0 (en) Pharmaceutical compounds
GB201308781D0 (en) Pharmaceutical compounds
PH32013000938S1 (en) Tablet computer
PH32013000937S1 (en) Tablet computer
PH32013000939S1 (en) Tablet computer